0.4914
Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
31.26%
1.39
|
1.059 | 1.412 | 1.456 | 1.279 |
|
36.28%
2.928
|
4.595 | 5.312 | 5.255 | 4.976 |
Benefits Costs and Expenses |
-
|
- | -13.49 | 4.33 | 4.219 |
Costs And Expenses |
36.28%
2.928
|
4.595 | 5.312 | 5.255 | 4.976 |
Operating Income/Loss |
56.50%
-1.538
|
-3.536 | -3.90 | -3.799 | -3.697 |
Nonoperating Income/Loss |
148.24%
6.689
|
-13.87 | -0.003 | 0.925 | 0.757 |
Income/Loss From Continuing Operations Before Tax |
107.99%
1.39
|
-17.40 | 14.90 | -2.874 | -2.94 |
Income/Loss From Continuing Operations After Tax |
129.60%
5.151
|
-17.40 | -3.903 | -2.874 | -2.94 |
|
129.60%
5.151
|
-17.40 | -3.903 | -2.874 | -2.94 |
Preferred Stock Dividends And Other Adjustments |
3.96
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
232.19%
48.39
|
14.57 | 0.4081 | 7.8558 | 6.5008 |
Diluted Average Shares |
1,336%
209.15
|
14.57 | -0.7516 | 7.8558 | 10.74 |
Basic Earnings Per Share |
101.68%
0.02
|
-1.19 | -0.49 | -0.37 | -0.45 |
Diluted Earnings Per Share |
99.16%
-0.01
|
-1.19 | -0.67 | -0.37 | -0.71 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
3.96
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):